Tandem Diabetes Care (TNDM) Prepaid Assets (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Prepaid Assets came in at $51.5 million in Q2 2026, up 80.98% on a YoY basis from $28.4 million in Q2 2025, and up 3.42% quarter-over-quarter from $49.8 million in Q1 2026.
Analysis
Tandem Diabetes Care (TNDM) Prepaid Assets (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported Prepaid Assets for 14 consecutive years, with $51.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Prepaid Assets rose 80.98% year-over-year to $51.5 million; the trailing twelve-month figure through Jun 2026 stood at $51.5 million (up 80.98% YoY), and the FY2025 full-year result was $31.2 million, up 42.12% from the prior year.
- Prepaid Assets climbed to $51.5 million in Q2 2026 per TNDM's latest filing, from $49.8 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $51.5 million in Q2 2026 and bottomed at $7.2 million in Q4 2022.
- Historically, Prepaid Assets has averaged $22.1 million across 5 years, with a median of $20.2 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets declined 14.13% in 2022, then soared 129.04% in 2023.
- Over 5 years, Prepaid Assets stood at $7.2 million in 2022, then jumped by 129.04% to $16.6 million in 2023, then jumped by 32.44% to $22.0 million in 2024, then surged by 42.12% to $31.2 million in 2025, then surged by 64.88% to $51.5 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $51.5 million, $49.8 million, and $31.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.26 Bn | 804.14 Mn | 144.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.47 Mn |
| Mar 31, 2026 | 49.77 Mn |
| Dec 31, 2025 | 31.22 Mn |
| Sep 30, 2025 | 34.61 Mn |
| Jun 30, 2025 | 28.44 Mn |
| Mar 31, 2025 | 27.08 Mn |
| Dec 31, 2024 | 21.97 Mn |
| Sep 30, 2024 | 19.89 Mn |
| Jun 30, 2024 | 21.20 Mn |
| Mar 31, 2024 | 20.53 Mn |
| Dec 31, 2023 | 16.59 Mn |
| Sep 30, 2023 | 16.18 Mn |
| Jun 30, 2023 | 10.75 Mn |
| Mar 31, 2023 | 15.38 Mn |
| Dec 31, 2022 | 7.24 Mn |
| Sep 30, 2022 | 8.00 Mn |
| Jun 30, 2022 | 7.85 Mn |
| Mar 31, 2022 | 8.95 Mn |
| Dec 31, 2021 | 8.43 Mn |
| Sep 30, 2021 | 6.76 Mn |